Madrid – CFI Spain is pleased to announce it acted as the exclusive corporate finance advisor of Ergon Capital Partners on the acquisition of a majority stake in Indo Optics from Sherpa Capital.
Ergon Capital is the private equity branch of Belgium Group GBL with more than €500m under management. Since its establishment in 2005, it has invested in 18 companies and has done more than 36 add-ons for its companies.
Headquartered in Sant Cugat del Vallès (Barcelona, Spain) and with a heritage of more than 80 years, Indo is the leading Spanish manufacturer of ophthalmic lenses and supplier of medical equipment distributor for the eye care sector, operating in two complementary business areas: (i) production of ophthalmic lenses, which are mainly sold to independent optical stores and leading optical retail chains; and (ii) distribution
of optical and ophthalmologic equipment, where the Company’s product offering is one of the widest in the Spanish market. Indo employs approximately 350 people and operates two state-of-the-art plants located in Spain (El Papiol/Barcelona) and Morocco (Tanger).
Sherpa Capital is a Spanish private equity founded in 2010 and specialised in turnaround investments and consolidation opportunities.
CFI Spain acted as exclusive financial advisor to Ergon Capital on the acquisition of a majority shareholding stake in Indo Optical. Sherpa, Oquendo Capital and the management have also taken minority stakes in the company. The transaction was announced on 21 June 2018.
The owners of
have sold a majority stake to
acquired the shares it did not already own in
Bioforce AG (Switzerland), which develops and produces phytopharmaceuticals, nutraceuticals and food supplements, acquired the shares it did not already own in the joint venture with Bioforce Denmark A/S (Denmark), which is the exclusive distributor of Bioforce products
has made a collection of Euro 50 million in form of Acquistion Financing